A carregar...

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms

Immune checkpoint inhibitors have shown efficacy in the treatment of non-small cell lung cancer (NSCLC) in the adjuvant, first- and subsequent-line settings. In metastatic disease, they provide hope of durable response where “best-case” scenario has long been inadequate. This progress has highlighte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Barnet, Megan B., Cooper, Wendy A., Boyer, Michael J., Kao, Steven
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6024943/
https://ncbi.nlm.nih.gov/pubmed/29904031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm7060151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!